Back to Search
Start Over
4MO Final overall survival (OS) data of sintilimab plus pemetrexed (SPP) and platinum as first-line (1L) treatment for locally advanced or metastatic nonsquamous NSCLC (AMnsqNSCLC) in the phase III ORIENT-11 study.
- Source :
-
Annals of Oncology . 2022 Supplement 2, Vol. 33, pS28-S28. 1p. - Publication Year :
- 2022
- Subjects :
- *OVERALL survival
*PEMETREXED
*PLATINUM
*NON-small-cell lung carcinoma
*METASTASIS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 155963099
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.02.013